IRIS Accounts Production v26.1.10.61 03220279 Board of Directors 1.2.25 31.1.26 31.1.26 Medium entities true false true true false false true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh032202792025-01-31032202792026-01-31032202792025-02-012026-01-31032202792024-01-31032202792024-02-012025-01-31032202792025-01-3103220279ns15:EnglandWales2025-02-012026-01-3103220279ns14:PoundSterling2025-02-012026-01-3103220279ns10:Director12025-02-012026-01-3103220279ns10:PrivateLimitedCompanyLtd2025-02-012026-01-3103220279ns10:MediumEntities2025-02-012026-01-3103220279ns10:Audited2025-02-012026-01-3103220279ns10:Medium-sizedCompaniesRegimeForDirectorsReport2025-02-012026-01-3103220279ns10:Medium-sizedCompaniesRegimeForAccounts2025-02-012026-01-3103220279ns10:FullAccounts2025-02-012026-01-3103220279ns10:OrdinaryShareClass12025-02-012026-01-3103220279ns10:Director22025-02-012026-01-3103220279ns10:RegisteredOffice2025-02-012026-01-310322027912025-02-012026-01-310322027912024-02-012025-01-310322027922025-02-012026-01-310322027922024-02-012025-01-3103220279ns5:CurrentFinancialInstruments2026-01-3103220279ns5:CurrentFinancialInstruments2025-01-3103220279ns5:ShareCapital2026-01-3103220279ns5:ShareCapital2025-01-3103220279ns5:CapitalRedemptionReserve2026-01-3103220279ns5:CapitalRedemptionReserve2025-01-3103220279ns5:RetainedEarningsAccumulatedLosses2026-01-3103220279ns5:RetainedEarningsAccumulatedLosses2025-01-3103220279ns5:ShareCapital2024-01-3103220279ns5:RetainedEarningsAccumulatedLosses2024-01-3103220279ns5:CapitalRedemptionReserve2024-01-3103220279ns5:RetainedEarningsAccumulatedLosses2024-02-012025-01-3103220279ns5:CapitalRedemptionReserve2024-02-012025-01-3103220279ns5:ShareCapital2025-02-012026-01-3103220279ns5:RetainedEarningsAccumulatedLosses2025-02-012026-01-3103220279ns5:CapitalRedemptionReserve2025-02-012026-01-3103220279ns5:LeaseholdImprovements2025-02-012026-01-3103220279ns5:FurnitureFittings2025-02-012026-01-3103220279ns5:ComputerEquipment2025-02-012026-01-3103220279ns5:OwnedAssets2025-02-012026-01-3103220279ns5:OwnedAssets2024-02-012025-01-3103220279ns10:OrdinaryShareClass12024-02-012025-01-3103220279ns5:LeaseholdImprovements2025-01-3103220279ns5:FurnitureFittings2025-01-3103220279ns5:ComputerEquipment2025-01-3103220279ns5:LeaseholdImprovements2026-01-3103220279ns5:FurnitureFittings2026-01-3103220279ns5:ComputerEquipment2026-01-3103220279ns5:LeaseholdImprovements2025-01-3103220279ns5:FurnitureFittings2025-01-3103220279ns5:ComputerEquipment2025-01-3103220279ns5:WithinOneYearns5:CurrentFinancialInstruments2026-01-3103220279ns5:WithinOneYearns5:CurrentFinancialInstruments2025-01-3103220279ns10:OrdinaryShareClass12026-01-3103220279ns5:RetainedEarningsAccumulatedLosses2025-01-3103220279ns5:CapitalRedemptionReserve2025-01-3103220279ns10:Director112025-01-3103220279ns10:Director112024-01-3103220279ns10:Director112025-02-012026-01-3103220279ns10:Director112024-02-012025-01-3103220279ns10:Director112026-01-3103220279ns10:Director112025-01-31
REGISTERED NUMBER: 03220279 (England and Wales)












Strategic Report, Report of the Directors and

Financial Statements

for the Year Ended 31 January 2026

for

Premier Nursing Agency Limited

Premier Nursing Agency Limited (Registered number: 03220279)






Contents of the Financial Statements
for the year ended 31 January 2026




Page

Company Information 1

Strategic Report 2

Report of the Directors 5

Report of the Independent Auditors 7

Income Statement 10

Other Comprehensive Income 11

Balance Sheet 12

Statement of Changes in Equity 13

Cash Flow Statement 14

Notes to the Cash Flow Statement 15

Notes to the Financial Statements 16


Premier Nursing Agency Limited

Company Information
for the year ended 31 January 2026







DIRECTORS: Mrs G Isterling
D Isterling





REGISTERED OFFICE: Premier Care, Lancaster House
Concorde Way
Millennium Business Park
Mansfield
Nottinghamshire
NG19 7DW





REGISTERED NUMBER: 03220279 (England and Wales)





AUDITORS: Clayton & Brewill
Statutory Auditors and
Chartered Accountants
Cawley House
149-155 Canal Street
Nottingham
Nottinghamshire
NG1 7HR

Premier Nursing Agency Limited (Registered number: 03220279)

Strategic Report
for the year ended 31 January 2026

The directors present their strategic report for the year ended 31 January 2026.

REVIEW OF BUSINESS
Premier Nursing Agency Ltd, trading as Premier Community, is a UK-based provider of homecare and domiciliary care services. The company's principal customers include local authorities alongside NHS and Private-pay Health Care Packages, and live-in care.

During the year ended 31 January 2026, the company generated turnover of £14,263,637 (2025: £11,612,084), a 23% increase year on year reflecting continued demand for the company's care services, and a growing market. This generated a profit of £1,066,655 (2025: £631,951). Net assets increased to £1,720,430 (31 January 2025: £1,398,746).

Alongside this financial growth, the directors consider the year to have been marked by strong non-financial progress, reflecting the investment made in the company's people, systems and service offering over 2025-26:

- Workforce investment and development: the company continued to invest significantly in training and development of its care workforce, supporting the delivery of high-quality, person-centred care and strengthening the pipeline of skilled carers.
- Recruitment and retention: sustained investment in recruitment activity supported the growth in care capacity needed to service rising demand, in a sector facing well-documented, sector-wide workforce shortages.
- Employee reward and wellbeing: the company continued to operate staff bonus, reward and recognition schemes, and recognises that it offers one of the most competitive carer wage rates in the region and an Employer Assistance programme.
- Further diversified its service mix during the year, particularly in privately funded Health Care Packages and commencing a new Live-in care service. The business continues to grow its core local authority contracts.
- Investment in systems and technology: continued investment in IT software and digital infrastructure supported operational scalability, care coordination and management reporting as the business has grown.
- Community and retail support: the company maintained its partnership with the Mobility stores during the year, reinforcing Premier Community's presence and reputation within the communities it serves.
- Governance framework; board-level oversight of strategy, risk and financial performance, underpinned by a defined branch/area management structure responsible for operational delivery, safeguarding and compliance.
- Quality of care and CQC compliance; registered locations operating under CQC oversight, supported by an internal quality assurance framework (care plan reviews, staff supervision, safeguarding, internal audit) to maintain compliance with CQC's fundamental standards as the business expands.

The directors view these achievements as key drivers behind the strong financial performance and balance sheet strength reported for the year, and as the foundation for the company's continued growth strategy into 2026-27.


Premier Nursing Agency Limited (Registered number: 03220279)

Strategic Report
for the year ended 31 January 2026

PRINCIPAL RISKS AND UNCERTAINTIES
Customer concentration and local authority fee rates

Local authorities accounted for a significant amount of turnover in the year. A reduction in commissioned hours, a failure to renew contracts, or fee rates that do not keep pace with cost inflation would have a material impact on the company's revenue and margins. The directors mitigate this risk by maintaining strong working relationships with commissioning bodies, and local Homecare Associations and networks, who collectively voice concerns and actively managing contract renewal and tender processes. Investing in Marketing teams and strategies to grow the proportion of turnover derived from Private-pay Health Care Packages, reflected in a 7.2% increase in turnover from FY 2024-25 to FY 2025-26.

Employee recruitment, retention and wage inflation

The homecare sector, both nationally and in the East Midlands, continues to face a well-documented shortage of care workers, with local commissioning bodies flagging home care workforce capacity as an ongoing challenge. This is compounded by rising labour costs, following successive increases in the National Living Wage and employer National Insurance, which sector-wide are generally outpacing corresponding local authority fee uplifts. As staff costs represent the great majority of the company's cost base, the company remains exposed to these pressures, and mitigates this through investment in recruitment, staff training, uniform and PPE provision, staff reward schemes, and partnership working with high street retail locations to maintain local presence and brand awareness.

Regulatory compliance and quality of care

As a regulated provider of care services, the company is subject to ongoing regulatory oversight and inspection, principally by the Care Quality Commission. Failure to maintain required standards of care could result in enforcement action, reputational damage, or loss of contracts with commissioning bodies. The directors mitigate this risk through a defined governance structure, with board-level oversight of quality and compliance supported by registered managers and branch teams responsible for day-to-day standards of care, and through continued investment in systems and process upgrades to strengthen care governance across the business. The company operates continuous monitoring of key operational KPIs, including late visits, visit durations, staffing levels and rostering, and care plan and safeguarding reviews, enabling early identification of emerging issues and supporting consistent, high-quality care delivery as the business continues to grow.

Margin pressure from cost inflation

With staff costs representing a significant percentage of turnover, the company's margins are sensitive to inflationary pressure on wages, National Insurance and other on-costs, which is not always fully recovered through fee negotiations with commissioners. The directors monitor cost performance closely through monthly management accounts and seek to negotiate fee uplifts in line with sector cost pressures where possible. The company also undertakes annual fee reviews for privately funded customers, and regularly reviews supplier contracts, running procurement processes as required to identify and secure further efficiencies.

KEY PERFORMANCE INDICATORS
The key performance indicators are as follows.

31 January 2026 31 January 2025
Turnover £14,263,637 £11,612,084
Profit before tax £1,066,655 £631,951
Net current assets £1,720,430 £1,398,746
Return on equity 0.68 0.36


Premier Nursing Agency Limited (Registered number: 03220279)

Strategic Report
for the year ended 31 January 2026

FUTURE DEVELOPMENTS
Management information prepared to 30 June 2026 indicates that the company's strong financial position has been maintained into the new financial year, with cash and cash equivalents of £1,506,457 and retained earnings of £1,633,036 at that date.

- Continuing to diversify the customer base by growing privately funded Health Care Packages and retail sales, which together represented over a fifth of turnover in the year, to reduce reliance on local authority contracts.
- Ongoing investment in recruitment, training and staff retention initiatives to address sector-wide care workforce shortages and support service quality.
- Continued investment in IT systems and infrastructure to support operational scalability.
- Active management of local authority fee negotiations and contract renewals to protect margins against continuing wage cost inflation.
- Ongoing monitoring of intercompany and group balances, and of the company's retail operations, as part of the wider group's development.

The directors remain confident in the company's prospects, supported by its trading performance during the year and its strengthened balance sheet position at the year end.

ON BEHALF OF THE BOARD:





D Isterling - Director


14 September 2026

Premier Nursing Agency Limited (Registered number: 03220279)

Report of the Directors
for the year ended 31 January 2026

The directors present their report with the financial statements of the company for the year ended 31 January 2026.

PRINCIPAL ACTIVITY
The principal activity of the company in the year under review was that of provision of home care services.

DIVIDENDS
No interim dividend was paid during the year. The directors recommend a final dividend of 462070 per share.

The total distribution of dividends for the year ended 31 January 2026 will be £ 468,089 .

DIRECTORS
The directors shown below have held office during the whole of the period from 1 February 2025 to the date of this report.

Mrs G Isterling
D Isterling

ENGAGEMENT WITH EMPLOYEES
It is the company's policy to provide equal opportunities to all employees and this policy applies to existing and prospective employees. The company provides appropriate training at all levels and endeavour to assist employees to acquire skills and experience which enable them to fulfil their role and develop their potential.

The company is committed to communication with employees by keeping them informed of performance and progress through briefings by management and the directors.

Full and fair consideration is given to applications for employment made by disabled persons, having regard to their particular abilities and career development is encouraged on the basis of their aptitudes and ability.

STREAMLINED ENERGY AND CARBON REPORTING
Given that consumption is less than 40,000kWh of energy, greenhouse gas emissions, energy consumption and energy efficiency disclosures are not given for that reason.

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

Premier Nursing Agency Limited (Registered number: 03220279)

Report of the Directors
for the year ended 31 January 2026


AUDITORS
The auditors, Clayton & Brewill, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





D Isterling - Director


14 September 2026

Report of the Independent Auditors to the Members of
Premier Nursing Agency Limited

Opinion
We have audited the financial statements of Premier Nursing Agency Limited (the 'company') for the year ended 31 January 2026 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 January 2026 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Report of the Independent Auditors to the Members of
Premier Nursing Agency Limited


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page five, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

- Enquiry of management around actual and potential litigation and claims;
- Reviewing minutes of meetings of those charged with governance;
- Reviewing financial statement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations;
- Performing audit work over the risk of management override of controls, including testing of journal entries and other adjustments for appropriateness, evaluating the business rationale of significant transactions outside the normal course of business and reviewing accounting estimates for bias.

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Other matters which we required to address
The comparative financial statements are unaudited. Our opinion on the current period's financial statements does not include the corresponding figures.

Report of the Independent Auditors to the Members of
Premier Nursing Agency Limited


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Mr Douglas Perry FCA (Senior Statutory Auditor)
for and on behalf of Clayton & Brewill
Statutory Auditors and
Chartered Accountants
Cawley House
149-155 Canal Street
Nottingham
Nottinghamshire
NG1 7HR

22 September 2026

Premier Nursing Agency Limited (Registered number: 03220279)

Income Statement
for the year ended 31 January 2026

2026 2025
Notes £    £   

REVENUE 14,263,637 11,612,084

Administrative expenses 13,262,468 11,036,534
1,001,169 575,550

Other operating income 42,893 45,990
OPERATING PROFIT 4 1,044,062 621,540

Interest receivable and similar income 22,593 10,411
PROFIT BEFORE TAXATION 1,066,655 631,951

Tax on profit 5 251,882 159,904
PROFIT FOR THE FINANCIAL YEAR 814,773 472,047

Premier Nursing Agency Limited (Registered number: 03220279)

Other Comprehensive Income
for the year ended 31 January 2026

2026 2025
Notes £    £   

PROFIT FOR THE YEAR 814,773 472,047


OTHER COMPREHENSIVE INCOME
Share buy back (25,000 ) -
Capital redemption reserve 3,250 -
Income tax relating to components of
other comprehensive income

-

-
OTHER COMPREHENSIVE INCOME
FOR THE YEAR, NET OF INCOME TAX

(21,750

)

-
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

793,023

472,047

Premier Nursing Agency Limited (Registered number: 03220279)

Balance Sheet
31 January 2026

2026 2025
Notes £    £    £    £   
FIXED ASSETS
Property, plant and equipment 7 126,724 65,397

CURRENT ASSETS
Debtors 8 1,512,863 1,858,888
Cash at bank 1,417,189 588,026
2,930,052 2,446,914
CREDITORS
Amounts falling due within one year 9 1,066,393 819,245
NET CURRENT ASSETS 1,863,659 1,627,669
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,990,383

1,693,066

ACCRUALS AND DEFERRED INCOME 10 269,953 294,320
NET ASSETS 1,720,430 1,398,746

CAPITAL AND RESERVES
Called up share capital 11 61,753 65,003
Capital redemption reserve 12 3,250 -
Retained earnings 12 1,655,427 1,333,743
SHAREHOLDERS' FUNDS 1,720,430 1,398,746

The financial statements were approved by the Board of Directors and authorised for issue on 14 September 2026 and were signed on its behalf by:





D Isterling - Director


Premier Nursing Agency Limited (Registered number: 03220279)

Statement of Changes in Equity
for the year ended 31 January 2026

Called up Capital
share Retained redemption Total
capital earnings reserve equity
£    £    £    £   
Balance at 1 February 2024 65,003 1,176,232 - 1,241,235

Changes in equity
Dividends - (314,536 ) - (314,536 )
Total comprehensive income - 472,047 - 472,047
Balance at 31 January 2025 65,003 1,333,743 - 1,398,746

Changes in equity
Issue of share capital (3,250 ) - - (3,250 )
Dividends - (468,089 ) - (468,089 )
Total comprehensive income - 789,773 3,250 793,023
Balance at 31 January 2026 61,753 1,655,427 3,250 1,720,430

Premier Nursing Agency Limited (Registered number: 03220279)

Cash Flow Statement
for the year ended 31 January 2026

2026 2025
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 1,537,894 4,533
Tax paid (159,695 ) (109,885 )
Net cash from operating activities 1,378,199 (105,352 )

Cash flows from investing activities
Purchase of tangible fixed assets (85,278 ) (40,764 )
Sale of tangible fixed assets - 337
Interest received 22,593 10,411
Net cash from investing activities (62,685 ) (30,016 )

Cash flows from financing activities
Amount introduced by directors 10,663 4,858
Amount withdrawn by directors (3,925 ) -
Share buyback (25,000 ) -
Equity dividends paid (468,089 ) (314,536 )
Net cash from financing activities (486,351 ) (309,678 )

Increase/(decrease) in cash and cash equivalents 829,163 (445,046 )
Cash and cash equivalents at
beginning of year

2

588,026

1,033,072

Cash and cash equivalents at end
of year

2

1,417,189

588,026

Premier Nursing Agency Limited (Registered number: 03220279)

Notes to the Cash Flow Statement
for the year ended 31 January 2026

1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM
OPERATIONS

2026 2025
£    £   
Profit before taxation 1,066,655 631,951
Depreciation charges 23,951 10,856
Loss on disposal of fixed assets - 9,536
Finance income (22,593 ) (10,411 )
1,068,013 641,932
Decrease/(increase) in trade and other debtors 339,603 (658,839 )
Increase in trade and other creditors 130,278 21,440
Cash generated from operations 1,537,894 4,533

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 January 2026
31.1.26 1.2.25
£    £   
Cash and cash equivalents 1,417,189 588,026
Year ended 31 January 2025
31.1.25 1.2.24
£    £   
Cash and cash equivalents 588,026 1,033,072


3. ANALYSIS OF CHANGES IN NET FUNDS

At 1.2.25 Cash flow At 31.1.26
£    £    £   
Net cash
Cash at bank 588,026 829,163 1,417,189
588,026 829,163 1,417,189
Total 588,026 829,163 1,417,189

Premier Nursing Agency Limited (Registered number: 03220279)

Notes to the Financial Statements
for the year ended 31 January 2026

1. STATUTORY INFORMATION

Premier Nursing Agency Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are prepared in sterling, which is the functional currency of the entity, rounded to the nearest £.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 20% on reducing balance
Fixtures and fittings - 20% on reducing balance
Computer equipment - 20% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Premier Nursing Agency Limited (Registered number: 03220279)

Notes to the Financial Statements - continued
for the year ended 31 January 2026

3. EMPLOYEES AND DIRECTORS
2026 2025
£    £   
Wages and salaries 9,680,927 8,436,842
Social security costs 1,011,983 570,895
Other pension costs 255,955 193,460
10,948,865 9,201,197

The average number of employees during the year was as follows:
2026 2025

Care and admin staff 658 550

2026 2025
£    £   
Directors' remuneration - -

4. OPERATING PROFIT

The operating profit is stated after charging:

2026 2025
£    £   
Venue Hire 85,978 129,363
Depreciation - owned assets 23,951 10,856
Loss on disposal of fixed assets - 9,536
Auditors' remuneration 12,000 -
Auditors' remuneration for non audit work 7,800 -
Foreign exchange differences - 2

5. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2026 2025
£    £   
Current tax:
UK corporation tax 251,882 159,904
Tax on profit 251,882 159,904

Tax effects relating to effects of other comprehensive income

2026
Gross Tax Net
£    £    £   
Share buy back (25,000 ) - (25,000 )
Capital redemption reserve 3,250 - 3,250
(21,750 ) - (21,750 )

6. DIVIDENDS
2026 2025
£    £   
Ordinary shares of £1 each
Final 468,089 314,536

Premier Nursing Agency Limited (Registered number: 03220279)

Notes to the Financial Statements - continued
for the year ended 31 January 2026

7. PROPERTY, PLANT AND EQUIPMENT
Improvements Fixtures
to and Computer
property fittings equipment Totals
£    £    £    £   
COST
At 1 February 2025 25,367 8,494 63,115 96,976
Additions 39,240 16,670 29,368 85,278
At 31 January 2026 64,607 25,164 92,483 182,254
DEPRECIATION
At 1 February 2025 496 3,058 28,025 31,579
Charge for year 11,305 2,617 10,029 23,951
At 31 January 2026 11,801 5,675 38,054 55,530
NET BOOK VALUE
At 31 January 2026 52,806 19,489 54,429 126,724
At 31 January 2025 24,871 5,436 35,090 65,397

8. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade debtors 148,897 163,306
Bad debt provision (1,735 ) -
Other debtors 1,062,074 1,031,422
Other debtors 5,100 17,685
Directors' current accounts - 6,422
Prepayments and accrued income 298,527 640,053
1,512,863 1,858,888

9. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade creditors 43,907 46,305
Tax 252,091 159,904
Social security and other taxes 326,390 268,641
Net wages 381,050 307,951
Pensions 35,387 32,026
Attachment of earnings orders 72 2,148
Other creditors 25,000 90
Directors' current accounts 2,496 2,180
1,066,393 819,245

10. ACCRUALS AND DEFERRED INCOME
2026 2025
£    £   
Accruals and deferred income 269,953 294,320

11. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2026 2025
value: £    £   
61,753 Ordinary £1 61,753 65,003

Premier Nursing Agency Limited (Registered number: 03220279)

Notes to the Financial Statements - continued
for the year ended 31 January 2026

12. RESERVES
Capital
Retained redemption
earnings reserve Totals
£    £    £   

At 1 February 2025 1,333,743 - 1,333,743
Profit for the year 814,773 814,773
Dividends (468,089 ) (468,089 )
Purchase of own shares (25,000 ) 3,250 (21,750 )
At 31 January 2026 1,655,427 3,250 1,658,677

13. PENSION COMMITMENTS

The amount recognised in profit or loss in relation to defined contribution plans was £255,955. Contributions payable for the year were £35,387.

14. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 January 2026 and 31 January 2025:

2026 2025
£    £   
D Isterling
Balance outstanding at start of year 6,422 9,900
Amounts advanced 3,926 -
Amounts repaid (10,348 ) (3,478 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - 6,422

15. RELATED PARTY DISCLOSURES

At the 31st January 2026 the company is owed £1,030,629 to Isterlings Ltd, a company in which D Isterling is a director. This balance is included within other debtors.